M
Michael H Neale
Researcher at University College London
Publications - 26
Citations - 1105
Michael H Neale is an academic researcher from University College London. The author has contributed to research in topics: Chemosensitivity assay & Melanoma. The author has an hindex of 16, co-authored 26 publications receiving 1051 citations. Previous affiliations of Michael H Neale include University of Leicester & Queen Alexandra Hospital.
Papers
More filters
Journal ArticleDOI
The E3 ubiquitin ligase Itch controls the protein stability of p63
Mario Rossi,Rami I. Aqeilan,Michael H Neale,Eleonora Candi,Paolo Salomoni,Richard A. Knight,Carlo M. Croce,Gerry Melino +7 more
TL;DR: It is shown that the Hect (homologous to the E6-associated protein C terminus)-containing Nedd4-like ubiquitin protein ligase Itch binds, ubiquitylates, and promotes the degradation of p63, suggesting that Itch has a fundamental role in the mechanism that controls endogenous p63 protein levels and therefore contributes to regulation of p 63 in physiological conditions.
Journal ArticleDOI
Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.
S R Boyd,Daniel Shao-Weng Tan,Catey Bunce,A Gittos,Michael H Neale,John L. Hungerford,S Charnock-Jones,Ian A. Cree +7 more
TL;DR: Though limited in number, the highest VEGF levels correlated with previous radiation therapy, and with the presence neovascularisation of the iris or optic nerve head, these data suggest that anti-VEGF therapy might prove useful in the management of some patients with NVI secondary to uveal melanoma.
Journal ArticleDOI
c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma
Jagdeep S. Chana,George S. Wilson,Ian A. Cree,Robert A. Alexander,N. E. Myatt,Michael H Neale,Alexander J E Foss,John L. Hungerford +7 more
TL;DR: The finding of improved rather than reduced survival in inc- myc positive tumours is at variance with skin melanoma, and there was no evidence to suggest that c-myc was modulated by upregulation ofBcl-2 or p53inactivation/mutation.
Journal ArticleDOI
PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.
Eliana Munarriz,Daniela Barcaroli,Anastasis Stephanou,Paul A. Townsend,C Maisse,Alessandro Terrinoni,Michael H Neale,Seamus J. Martin,David S. Latchman,Richard A. Knight,Gerry Melino,Gerry Melino,Vincenzo De Laurenzi,Vincenzo De Laurenzi +13 more
TL;DR: It is shown that p73α, -β, and -γ bind to the protein inhibitor of activated STAT-1 (PIAS-1) and that this binding stabilizes p73, and that PIas-1-mediated sumoylation decreases p73 transcriptional activity on several target promoters, such as Bax.
Journal ArticleDOI
Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside.
Michael H Neale,N. E. Myatt,Ian A. Cree,Christian M. Kurbacher,Alexander J E Foss,John L. Hungerford,P. N. Plowman +6 more
TL;DR: The combination of treosulfan with gemcitabine or cytosine arabinoside shows activity ex vivo against primary tumour tissue in choroidal melanoma patients.